Nevirapine

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Nevirapine are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Nevirapine?

The molecule Nevirapine presents a molecular formula of C15H14N4O and its IUPAC name is 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one.

Nevirapine (NVP), sold under the brand names Viramune among others, is a medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI)..

Common side effects include rash, headache, and nausea. Serious side effects may include liver problems, Stevens–Johnson syndrome, and lactic acidosis. Use during pregnancy may harm the baby. NVP is an inhibitor of CYP3A4..

NVP was first made in 1987 and approved for medical use in 1996. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. NVP exists as a generic medication. In 2017, it was the 243rd most commonly prescribed medication in the United States, with more than one million prescriptions..

NVP is used to treat HIV/AIDS. It is generally recommended for use with other antiretrovirals..

NVP is also used to prevent mother-to-child transmission (MTCT) of HIV. NVP is given to the mother during labor and delivery, and to the infant starting at two weeks of age..

The most common side effects of NVP include rash, headache, and nausea..

Serious side effects of NVP may include liver problems, Stevens–Johnson syndrome, and lactic acidosis..

Use of NVP during pregnancy may harm the baby..

NVP is an inhibitor of CYP3A4..

NVP was first made in 1987 and approved for medical use in 1996..

NVP is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system..

NVP exists as a generic medication. In 2017, it was the 243rd most commonly prescribed medication in the United States, with more than one million prescriptions..

3D structure

Cartesian coordinates

Geometry of Nevirapine in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Nevirapine NQDJXKOVJZTUJA-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Nevirapine

 

Molecule descriptors

 
IUPAC name2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
InChI codeInChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
InChI KeyNQDJXKOVJZTUJA-UHFFFAOYSA-N
SMILESCc1ccnc2c1NC(=O)c1cccnc1N2C1CC1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE
  • 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
  • 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
  • 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
  • 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one
  • 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
  • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
  • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one
  • 11-cyclopropyl-4-methyl-5H-dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one
  • 11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one
  • 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one
  • 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one
  • 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
  • 129618-40-2
  • 1vrt
  • 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
  • 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
  • 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
  • 2hny
  • 618N402
  • 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-
  • 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
  • 6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
  • 99DK7FVK1H
  • AB00393001-13
  • AB00393001-15
  • AB00393001_16
  • AB00393001_17
  • AB07544
  • AC-643
  • AC1280
  • BBL010768
  • BCP05587
  • BDBM1434
  • BI-RG 587
  • BI-RG 587;NSC 641530;NVP
  • BI-RG-587
  • BI-RG-587 & CD4-IgG
  • BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; NSC 641530; NVP
  • BIDD:GT0326
  • BIRG 0587
  • BIRG 587
  • BIRG-0587
  • BIRG-587
  • BIRG587
  • C07263
  • CCG-100939
  • D00435
  • DB-041930
  • DB00238
  • DSSTox_CID_10787
  • DSSTox_GSID_31797
  • DSSTox_RID_78889
  • F2173-0607
  • FT-0607215
  • FT-0672686
  • HMS2051J09
  • HMS2231O23
  • HMS3264D21
  • HMS3371E03
  • HMS3393J09
  • HMS3655I08
  • HMS3715B10
  • HSDB 7164
  • HY-10570
  • KS-5019
  • MFCD00866928
  • MLS000084585
  • MLS000759409
  • MLS001055309
  • MLS001201730
  • MLS001424058
  • MLS006011423
  • N0922
  • N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
  • NC00189
  • NCGC00065890-02
  • NCGC00065890-03
  • NCGC00065890-04
  • NCGC00065890-05
  • NCGC00065890-07
  • NCGC00065890-14
  • NCGC00258324-01
  • NEV
  • NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
  • NSC 641530
  • NSC-641530
  • NSC-759902
  • NSC641530
  • NSC759902
  • NVP
  • Nevirapine
  • Nevirapine & CD4-IgG
  • Nevirapine & PRO 140
  • Nevirapine (JAN/USP/INN)
  • Nevirapine (Viramune)
  • Nevirapine anhydrous
  • Nevirapine teva
  • Nevirapine)
  • Nevirapine, anhydrous
  • Nevirapine,(S)
  • Nevirapinum anhydrous
  • Opera_ID_934
  • Pharmakon1600-01503842
  • Q263713
  • S1742
  • SMR000048458
  • STK580320
  • SW197569-2
  • SY009679
  • Tox21 110982
  • Viramune
  • Viramune IR
  • Viramune XR
  • Viramune(TM)
  • Z1695906730
  • nevirapine

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC4778
  • CAS-129618-40-2
  • UNII-99DK7FVK1H
  • AKOS005504351
  • ALBB-027264
  • DTXSID7031797
  • CHEMBL57
  • CHEBI:63613
  • Tox21_110982
  • Tox21_200770
  • Tox21_110982_1
  • SCHEMBL3318

Physico-Chemical properties

IUPAC name2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
Molecular formulaC15H14N4O
Molecular weight266.298
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity78.20
LogP2.5
Topological polar surface area63.6

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.